Abrdn Life Sciences Investors (HQL) Short Interest Ratio & Short Volume $14.29 +0.08 (+0.56%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Abrdn Life Sciences Investors Short Interest DataAbrdn Life Sciences Investors (HQL) has a short interest of 63,200 shares. This marks a 1.44% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 66,032 shares to cover all short positions.Current Short Interest63,200 sharesPrevious Short Interest62,300 sharesChange Vs. Previous Month+1.44%Dollar Volume Sold Short$920,192.00Short Interest Ratio1.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares27,350,000 sharesPercentage of Shares Shorted0.23%Today's Trading Volume132,847 sharesAverage Trading Volume66,032 sharesToday's Volume Vs. Average201% Short Selling Abrdn Life Sciences Investors? Sign up to receive the latest short interest report for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHQL Short Interest Over TimeHQL Days to Cover Over TimeHQL Percentage of Float Shorted Over Time Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Abrdn Life Sciences Investors Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202463,200 shares $920,192.00 +1.4%N/A1 $14.56 10/15/202462,300 shares $931,385.00 -58.9%N/A0.9 $14.95 9/30/2024151,500 shares $2.28 million -1.7%N/A1.6 $15.07 9/15/2024154,100 shares $2.35 million -10.8%N/A1.6 $15.28 8/31/2024172,800 shares $2.61 million -22.0%N/A1.9 $15.13 8/15/2024221,500 shares $3.42 million -16.1%N/A2.4 $15.44 Get the Latest News and Ratings for HQL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024264,100 shares $4.06 million +4,978.9%N/A2.7 $15.37 7/15/20245,200 shares $79,456.00 -67.7%N/A0.1 $15.28 6/30/202416,100 shares $228,137.00 +67.7%N/A0.2 $14.17 6/15/20249,600 shares $132,671.04 -72.4%N/A0.1 $13.82 5/31/202434,800 shares $463,536.00 -52.7%N/A0.4 $13.32 5/15/202473,600 shares $1.05 million +26.0%N/A0.9 $14.27 4/30/202458,400 shares $765,624.00 +205.8%N/A0.6 $13.11 4/15/202419,100 shares $247,918.00 -10.3%N/A0.2 $12.98 3/31/202421,300 shares $290,319.00 -27.6%N/A0.2 $13.63 3/15/202429,400 shares $396,900.00 -47.5%N/A0.2 $13.50 2/29/202456,000 shares $767,200.00 -58.0%N/A0.4 $13.70 2/15/2024133,400 shares $1.87 million +895.5%N/A1 $14.05 1/31/202413,400 shares $183,848.00 -86.2%N/A0.1 $13.72 1/15/202496,900 shares $1.37 million +37.1%N/A0.8 $14.16 12/31/202370,700 shares $951,622.00 +30.2%N/A0.5 $13.46 12/15/202354,300 shares $714,045.00 +18.0%N/A0.4 $13.15 11/30/202346,000 shares $549,240.00 -51.0%N/A0.4 $11.94 11/15/202393,800 shares $1.13 million +186.0%N/A0.8 $12.04 10/31/202332,800 shares $380,152.00 -42.9%N/A0.3 $11.59 10/15/202357,400 shares $704,872.00 +71.9%N/A0.5 $12.28 9/30/202333,400 shares $416,498.00 -7.2%N/A0.3 $12.47 9/15/202336,000 shares $461,880.00 +40.1%N/A0.4 $12.83 8/31/202325,700 shares $334,357.00 +71.3%N/A0.3 $13.01 8/15/202315,000 shares $201,300.00 -63.0%N/A0.2 $13.42 7/31/202340,500 shares $544,725.00 +282.1%N/A0.4 $13.45 7/15/202310,600 shares $142,146.00 -85.7%N/A0.1 $13.41 6/30/202374,000 shares $1.00 million +695.7%N/A1 $13.55 6/15/20239,300 shares $128,712.00 No ChangeN/A0.1 $13.84 5/31/20239,300 shares $123,597.00 -76.6%N/A0.1 $13.29 5/15/202339,800 shares $559,588.00 -27.2%N/A0.5 $14.06 4/30/202354,700 shares $761,971.00 -2.0%N/A0.7 $13.93 4/15/202355,800 shares $782,874.00 -1.8%N/A0.7 $14.03 3/31/202356,800 shares $791,224.00 -45.8%N/A0.7 $13.93 3/15/2023104,700 shares $1.44 million +408.3%N/A1 $13.72Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. 2/28/202320,600 shares $287,576.00 +186.1%N/A0.2 $13.96 2/15/20237,200 shares $105,336.00 -22.6%N/A0.1 $14.63 1/31/20239,300 shares $138,942.00 -17.7%N/A0.1 $14.94 1/15/202311,300 shares $166,788.00 -50.9%N/A0.1 $14.76 12/30/202223,000 shares $326,830.00 +62.0%N/A0.2 $14.21 12/15/202214,200 shares $209,024.00 -10.7%N/A0.1 $14.72 11/30/202215,900 shares $239,772.00 +28.2%N/A0.2 $15.08 11/15/202212,400 shares $186,620.00 +7.8%N/A0.1 $15.05 10/31/202211,500 shares $168,475.00 -62.9%N/A0.1 $14.65 10/15/202231,000 shares $427,490.00 No ChangeN/A0.4 $13.79 9/30/202224,000 shares $327,840.00 -33.9%N/A0.3 $13.66 9/15/202236,300 shares $537,240.00 +80.6%N/A0.5 $14.80 8/31/202220,100 shares $290,244.00 +55.8%N/A0.3 $14.44 8/15/202212,900 shares $210,399.00 +79.2%N/A0.2 $16.31 7/31/20227,200 shares $107,424.00 -77.1%N/A0.1 $14.92 7/15/202231,400 shares $475,082.00 +91.5%N/A0.4 $15.13 6/30/202216,400 shares $233,372.00 +11.6%N/A0.2 $14.23 6/15/202214,700 shares $198,156.00 +110.0%N/A0.2 $13.48 5/31/20227,000 shares $101,990.00 -84.6%N/A0.1 $14.57 5/15/202245,400 shares $653,760.00 -30.5%N/A0.6 $14.40 4/30/202265,300 shares $1.01 million +262.8%N/A0.9 $15.49 4/15/202218,000 shares $303,660.00 -1.1%N/A0.2 $16.87 3/31/202218,200 shares $301,028.00 -55.6%N/A0.2 $16.54 3/15/202241,000 shares $637,550.00 -67.6%N/A0.4 $15.55 2/28/2022126,600 shares $2.09 million -36.0%N/A1.4 $16.47 2/15/2022197,700 shares $3.48 million -18.6%N/A2.1 $17.61 1/31/2022243,000 shares $4.41 million +130.6%N/A2.8 $18.15 1/15/2022105,400 shares $1.96 million +626.9%N/A1.2 $18.56 12/31/202114,500 shares $278,835.00 -85.8%N/A0.2 $19.23 12/15/2021102,200 shares $1.95 million -5.0%N/A1.5 $19.10 11/30/2021107,600 shares $2.13 million -29.9%N/A1.7 $19.84 11/15/2021153,400 shares $3.15 million -0.5%N/A2.5 $20.54 10/29/2021154,100 shares $3.28 million +553.0%N/A2.2 $21.27 10/15/202123,600 shares $487,576.00 +34.9%N/A0.3 $20.66 9/30/202117,500 shares $364,000.00 -61.8%N/A0.3 $20.80 9/15/202145,800 shares $996,608.00 +70.3%N/A0.7 $21.76 8/31/202126,900 shares $587,765.00 -40.5%N/A0.4 $21.85 8/13/202145,200 shares $980,840.00 +396.7%N/A0.6 $21.70 7/30/20219,100 shares $189,280.00 +37.9%N/A0.1 $20.80 7/15/20216,600 shares $135,894.00 -85.5%N/A0.1 $20.59 6/30/202145,500 shares $975,520.00 +792.2%N/A0.6 $21.44 6/15/20215,100 shares $106,335.00 -88.5%N/A0.1 $20.85 5/28/202144,400 shares $884,892.00 -5.7%N/A0.5 $19.93 5/14/202147,100 shares $901,494.00 -12.9%N/A0.5 $19.14 4/30/202154,100 shares $1.10 million +12.0%N/A0.6 $20.34 4/15/202148,300 shares $951,993.00 -60.5%N/A0.6 $19.71 3/31/2021122,300 shares $2.39 million +38.7%N/A1.4 $19.51 3/15/202188,200 shares $1.78 million -23.8%N/A1.1 $20.23 2/26/2021115,700 shares $2.43 million +105.9%N/A1.4 $21.00 2/12/202156,200 shares $1.23 million +561.2%N/A0.7 $21.85Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. 1/29/20218,500 shares $171,785.00 -76.7%N/A0.1 $20.21 1/15/202136,400 shares $744,016.00 -25.3%N/A0.5 $20.44 12/31/202048,700 shares $963,773.00 +549.3%N/A0.6 $19.79 12/15/20207,500 shares $145,200.00 -86.4%N/A0.1 $19.36 11/30/202055,000 shares $1.03 million +63.7%N/A0.7 $18.73 11/15/202033,600 shares $612,864.00 -19.2%N/A0.4 $18.24 10/30/202041,600 shares $715,104.00 +222.5%N/A0.5 $17.19 10/15/202012,900 shares $236,844.00 -18.4%N/A0 $18.36 9/30/202015,800 shares $277,764.00 -81.4%N/A0.2 $17.58 9/15/202011,000 shares $196,350.00 -87.1%N/A0.1 $17.85 8/31/202085,000 shares $1.52 million +135.5%N/A1 $17.83 8/14/202036,100 shares $646,190.00 -37.4%N/A0.4 $17.90 7/31/202057,700 shares $1.03 million +262.9%N/A0.6 $17.91 7/15/202015,900 shares $293,832.00 +40.7%N/A0.2 $18.48 6/30/202011,300 shares $199,332.00 -65.7%N/A0.1 $17.64 6/15/202032,900 shares $567,854.00 -9.6%N/A0.3 $17.26 5/29/202036,400 shares $642,460.00 +318.4%N/A0.3 $17.65 5/15/20208,700 shares $150,945.00 -71.8%N/A0.1 $17.35 4/30/202030,800 shares $528,836.00 +13.7%N/A0.2 $17.17 4/15/202027,100 shares $437,394.00 +88.2%N/A0.2 $16.14 3/31/202014,400 shares $250,128.00 +251.2%N/A0.1 $17.37 3/13/20204,100 shares $64,288.00 -87.4%0.0%0 $15.68 2/28/202032,400 shares $403,056.00 +356.3%N/A0.3 $12.44 2/14/20207,100 shares $112,109.00 -57.2%N/A0.1 $15.79 1/31/202016,600 shares $284,856.00 -5.1%N/A0.2 $17.16 1/15/202017,500 shares $311,500.00 +25.9%N/A0.2 $17.80 12/31/201913,900 shares $237,551.00 -35.1%N/A0.1 $17.09 HQL Short Interest - Frequently Asked Questions What is Abrdn Life Sciences Investors' current short interest? Short interest is the volume of Abrdn Life Sciences Investors shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 63,200 shares of HQL short. Learn More on Abrdn Life Sciences Investors' current short interest. What is a good short interest ratio for Abrdn Life Sciences Investors? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HQL shares currently have a short interest ratio of 1.0. Learn More on Abrdn Life Sciences Investors's short interest ratio. Is Abrdn Life Sciences Investors' short interest increasing or decreasing? Abrdn Life Sciences Investors saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 63,200 shares, an increase of 1.4% from the previous total of 62,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Abrdn Life Sciences Investors' short interest compare to its competitors? Here is how the short interest of companies in the industry of "financial services" compare to Abrdn Life Sciences Investors: MidCap Financial Investment Co. (0.34%), New Mountain Finance Co. (1.96%), Bain Capital Specialty Finance, Inc. (0.40%), Barings BDC, Inc. (0.56%), Abrdn Healthcare Investors (0.15%), Carlyle Secured Lending, Inc. (0.69%), John Hancock Financial Opportunities Fund (0.05%), PIMCO High Income Fund (0.05%), Eagle Point Credit Company Inc. (1.15%), Nuveen Select Tax-Free Income Portfolio (0.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Abrdn Life Sciences Investors stock? Short selling HQL is an investing strategy that aims to generate trading profit from Abrdn Life Sciences Investors as its price is falling. HQL shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Abrdn Life Sciences Investors? A short squeeze for Abrdn Life Sciences Investors occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HQL, which in turn drives the price of the stock up even further. How often is Abrdn Life Sciences Investors' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HQL, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies MidCap Financial Investment Short Interest Data New Mountain Finance Short Interest Data Bain Capital Specialty Finance Short Interest Data Barings BDC Short Interest Data Abrdn Healthcare Investors Short Interest Data Carlyle Secured Lending Short Interest Data John Hancock Financial Opportunities Fund Short Interest Data PIMCO High Income Fund Short Interest Data Eagle Point Credit Short Interest Data Nuveen Select Tax-Free Income Portfolio Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:HQL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share Abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
